Human Papillomavirus and Cytomegalovirus Therapeutics Market - Global Industry Analysis 2015 for the $2.34 Billion Market
M2 - Mon Apr 20, 8:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8lwwcf/_human) has announced the addition of the "Human Papillomavirus (By Drug Class and Applications) and Cytomegalovirus (By Drug Type and Applications) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global HPV therapeutics market was valued at USD 1,402.3 million in 2012 and is expected to reach USD 2,346.5 million by 2020, growing at a CAGR of 7.7% from 2014 to 2020. Human papillomavirus (HPV) and Cytomegalovirus (CMV) therapeutics market report studies current as well as future prospects of the market on a global scale. The global market for HPV therapeutics is segmented by drug class and applications. Various drug classes applied against HPV infections are immunomodulators, keratolytic agents, anti-neoplastic agents, and sinecatechins. The HPV therapeutics market is studied by application segments which include genital warts, genital cancers, epidermodysplasia verriformis, oral papillomas, and others (oropharyngeal cancer, laryngeal papillomatosis and others). The global HPV therapeutics market has been extensively analyzed on the basis of the effectiveness and sales revenue of major drug classes as well as geographic prevalence of various HPV infections. The global CMV therapeutics market is segmented by drugs and applications. The major drugs prescribed for the treatment of CMV infections are ganciclovir, valganciclovir, foscarnet, and cidofovir. The CMV therapeutics treatment is applied against various CMV infections causing retinitis, pneumonia, gastrointestinal ulcers, encephalitis and others (mouth ulcers, pharyngitis and others). Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global HPV and CMV Therapeutics Market Overview Chapter 4 Global HPV Therapeutics Market Chapter 5 Global Cytomegalovirus Therapeutics Market Chapter 6 Global HPV and CMV Therapeutics Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - AbbVie, Inc. - Actavis plc - Clinigen Group plc - Merck & Co., Inc. - Perrigo Company plc - Roche Holdings AG - Valeant Pharmaceuticals International, Inc. For more information visit http://www.researchandmarkets.com/research/8lwwcf/_human
PRGO: 194.50 (+0.35), MRK: 60.23 (+0.45), ABBV: 65.99 (+0.02), VRX.TO: 270.02 (+2.67)
Clinigen Group plc: Half Year Revenues up 17% to £72.6m, Underlying EBITDA up 8% to £13.5m
Business Wire - Tue Mar 03, 1:08AM CST
Clinigen Group plc (AIM: CLIN, Clinigen or the Group), the global specialty pharmaceuticals and pharmaceutical services business, has today published its half year results for the six months ended 31 December 2014.
Clinigen Group plc Receives FDA's First Ever Drug Shortage Assistance Award
Business Wire - Mon Sep 29, 1:28AM CDT
Clinigen Group plc ('Clinigen' or the 'Group', AIM:CLIN) the global specialty pharmaceutical company, today announces that it has received the first Drug Shortage Assistance Award from the US Food and Drug Administration (FDA) in recognition of its contribution in addressing a US shortage of Foscavir(R) (foscarnet sodium) injection.
Clinigen Group plc: Underlying EBITDA up 19.8% and EPS up 22%
Business Wire - Wed Sep 24, 1:10AM CDT
Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global specialty pharmaceuticals business, has today published its preliminary results for the 12 months ended 30 June 2014.
New Antibiotic VIBATIV(R)a- 1/4 (telavancin) Targets Public Health Priority MRSA Infections for People with Hospital-Acquired Pneumonia Across Europe
PR Newswire Europe - Thu Sep 18, 7:42AM CDT
BURTON-ON-TRENT, England, September 18, 2014 /PRNewswire/ --
Clinigen Group Further Strengthens Oncology Support Portfolio with Acquisition of Ethyol(R) (amifostine), from AstraZeneca
Business Wire - Wed Aug 20, 1:07AM CDT
Clinigen Group plc ('Clinigen' or the 'Group'